心肌梗塞
医学
肌钙蛋白复合物
心脏病学
接收机工作特性
内科学
肌钙蛋白I
生物医学工程
检出限
周转时间
生物标志物
临床诊断
肌钙蛋白
频谱分析仪
急诊分诊台
临床实习
金标准(测试)
检测点注意事项
诊断准确性
拉曼散射
作者
Jingjing Zhang,Lan Wang,Qian Peng,Yongheng Li,Xiyu He,Jian Liu,Wei Sun,Lianhui Wang,Chunyuan Song
出处
期刊:ACS Sensors
[American Chemical Society]
日期:2026-11-12
标识
DOI:10.1021/acssensors.6c03789
摘要
Rapid clinical decision-making for acute myocardial infarction (AMI) relies on the timely and precise assessment of cardiac biomarkers. However, detecting cardiac troponin I (cTnI), as the gold-standard biomarker for AMI, with both laboratory-grade sensitivity and rapid clinical turnaround remains a formidable challenge in point-of-care (POC) settings. To address this, we develop a one-pot surface-enhanced Raman scattering (SERS) aptasensor that integrates aptamer-mediated cTnI recognition, catalytic hairpin assembly (CHA) amplification, and plasmonic hotspot assembly. The assay supports two kinetic operating modes within the same assay: a 60-min high-sensitivity mode with a serum limit of detection (LOD) of 53.58 fg/mL and a 20-min rapid-triage mode with an LOD of 14.25 pg/mL, below the clinical decision threshold of 40 pg/mL. In a cohort of 100 clinical serum samples, the bootstrap optimism-corrected diagnostic accuracy was 91.3% for the SERS aptasensor, significantly outperforming conventional ELISA (77.8%). In a subset of 94 subjects with available routine cTnT results, the SERS-cTnI assay achieved an area under the receiver operating characteristic curve (AUC) of 0.988, comparable to that of the hospital's routine chemiluminescence cTnT assay (0.976), supporting its potential as a complementary diagnostic tool for cTnI-based AMI assessment. Furthermore, compatibility with a handheld Raman spectrometer was evaluated in an independent validation cohort (n = 36), achieving 97.2% accuracy using only 4 μL of serum within 20 min following serum preparation. This reliable one-pot SERS platform bridges ultra-sensitive detection and rapid portable readout, holding promise as a potential tool for future decentralized cardiovascular POC diagnostics.
科研通智能强力驱动
Strongly Powered by AbleSci AI